1993
DOI: 10.1016/s0272-6386(12)70313-x
|View full text |Cite
|
Sign up to set email alerts
|

Renal Malacoplakia Reappraised

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
76
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 71 publications
(78 citation statements)
references
References 41 publications
2
76
0
Order By: Relevance
“…Michealis-Guttman bodies, a pathognomonic feature of renal malakoplakia, are never seen in any other condition including granulomatous pyelitis; furthermore, malakoplakia usually involves the renal parenchyma rather than the renal pelvis. 16,18,19 Necrotizing granulomatous inflammation and pyelocalyceal dilatation are seen in both renal tuberculosis and granulomatous pyelitis; however, renal tuberculosis is characterized by granulomatous inflammation involving predominantly the renal parenchyma, and much less frequently affecting the pyelocalyceal system; other characteristic features of renal tuberculosis including simultaneous active infection of lung or other genitourinary organs, frequent bilateral renal involvement, and positive acid fast bacilli by special stains or culture should be definitive. 16 Fungal infection of the kidney is almost always limited to immunosuppressed patients, with renal involvement reminiscent of acute pyelonephritis rather than granulomatous inflammation; it is associated with abundant organisms detected by special stains, but prominant pyelocalyceal involvement or urinary tract obstruction is not features of renal fungal infection.…”
Section: Discussionmentioning
confidence: 99%
“…Michealis-Guttman bodies, a pathognomonic feature of renal malakoplakia, are never seen in any other condition including granulomatous pyelitis; furthermore, malakoplakia usually involves the renal parenchyma rather than the renal pelvis. 16,18,19 Necrotizing granulomatous inflammation and pyelocalyceal dilatation are seen in both renal tuberculosis and granulomatous pyelitis; however, renal tuberculosis is characterized by granulomatous inflammation involving predominantly the renal parenchyma, and much less frequently affecting the pyelocalyceal system; other characteristic features of renal tuberculosis including simultaneous active infection of lung or other genitourinary organs, frequent bilateral renal involvement, and positive acid fast bacilli by special stains or culture should be definitive. 16 Fungal infection of the kidney is almost always limited to immunosuppressed patients, with renal involvement reminiscent of acute pyelonephritis rather than granulomatous inflammation; it is associated with abundant organisms detected by special stains, but prominant pyelocalyceal involvement or urinary tract obstruction is not features of renal fungal infection.…”
Section: Discussionmentioning
confidence: 99%
“…11,15 The kidney is involved in approximately 15% of cases, with 75% of these affecting women. 5,15 Fine needle aspiration (FNA) diagnosis of malacoplakia has been reported for the thyroid, 7 gastrointestinal tract, 1,9 skin, 4 vagina, 14 pelvis, 12 prostate, 3,13 lymph nodes 8 and lung. 16 To our knowledge this is the first report of renal malacoplakia diagnosed by fine needle aspiration.…”
mentioning
confidence: 99%
“…As many authors agree there is a decreased intra cellular cGMP/cAMP ratio that seems to diminish capacity of macrophages for bacterial lysis. Hence, in Malacoplakia the assumption exists that the underlying cellular defect is the impaired intracellular killing of bacteria [169,170]. The most frequent bacteria associated with malacoplakia are coliforms that in 75% of cases is E. coli [169].…”
Section: Pathogenesismentioning
confidence: 99%
“…For the malacoplakia in the urinary tract, the female to male ratio is 4:1; however, this ratio does not stand for other body tissues [168,169]. The affected patients who are mostly debilitated, are immunosuppressed, with other chronic diseases and they are similar to those patients on long-term steroid administration and individuals with acquired immunodeficiency syndrome, lymphoma, and diabetes mellitus [168].…”
Section: Clinical Presentationmentioning
confidence: 99%
See 1 more Smart Citation